期刊文献+

宫颈细胞学技术的研究进展及临床意义 被引量:5

下载PDF
导出
出处 《福建中医学院学报》 2005年第S1期33-35,共3页 Journal of Fujian College of Traditional Chinese Medicine
  • 相关文献

参考文献8

二级参考文献11

  • 1章文华,孙建衡,吴爱如,吴令英,白萍,吴小红,晁红霞,王希霞,王月秀,路兰香.宫颈癌普查中应用阴道镜的初步报告[J].中华肿瘤杂志,1994,16(1):59-62. 被引量:30
  • 2曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2000.1755.
  • 3潘凌亚.2001 Bethesda系统及其处理指南[N].中国医学论坛报,2002-10-24(13).
  • 4Miller BE. Carcinoma of the cervical stump. Gynecol Oncol, 1984, 18:100.
  • 5New Pap Smear Technologies Promise Improved Sensitivity. 2000 by RR Inc. Http://www. cancemetwork. com /journals/ oncnews /n 9906v. htm.
  • 6Savage EW, Chapman G. Cervical dysplasia and cancer. In: Hacker NF, Moore JG. Essentials of Obstetrics and Gynecology. 3rd ed.Philadelphia: Saunders, 1998. 645.
  • 7Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of woman with cervical cytological abnormalities. JAMA,2002,287 ( 16 ) :2120.
  • 8Lipscomb G H. Abnormal Pap Smear. In : Ling FW, Duff P (eds) Obstetrics and Gynecology, Principles for Practice. Beijing: McGraw-Hil1,2001. 1096.
  • 9Lonky NM, Sadeghi M, Tsadik GW, et al. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol,1999,181:560-566.
  • 10Rokyta Z. Diagnostic reliability of prebioptic methods in the prediction of a histological basis of cervical lesions and its correlation with accuracy of colposcopically directed biopsy in patients with cervical neoplasia. Eur J Gynecol Oncol,2000,21:484-486.

共引文献1580

同被引文献26

  • 1刘向阳,冯飞跃,赵守华.美国癌症学会(ACS)2004年版癌症早期筛查指南解读(二)[J].中国医刊,2004,39(7):49-50. 被引量:23
  • 2周琦.子宫颈癌与人乳头状瘤病毒感染[J].肿瘤学杂志,2005,11(2):81-82. 被引量:7
  • 3孙海艳,袁亚敏,魏绍斌.HPV感染与宫颈癌的预防[J].江西中医药,2006,37(9):11-12. 被引量:8
  • 4李琴艳,杨庆忠,付雯.TCT与巴氏细胞学在宫颈癌筛查中的对比研究[J].中国妇幼保健,2007,22(9):1173-1174. 被引量:29
  • 5Renshaw AA, Young NAB, Irdsong GG, et al. Comparison of perform- ance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program [ J 1. Arch Pathol Lab Med ,2004,128 ( 1 ) : 17-22.
  • 6Lynqe E, Reboli M. Primary HPV screening for cervical cancer pre- vention : results from European trials[ J]. Nst Rev Clin Oncol, 2009, 6(12) : 699-706.
  • 7An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus(HPV) genotypes detected with the HPV DNA chip microarray method [ J]. Cancer, 2003, 97(7) : 1672-1680.
  • 8Munoz N,Castellsague X,de Gonzalez AB, et al.HPV in the etiology of human cancer[].Vaccine.2006
  • 9Lynqe E,Antilla A,Arbyn M,et al.What’’s next?Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination[].European Journal of Cancer.2009
  • 10Fife KH,GramerHM,Schroeder JM,et a.I.Detection ofmultiplehuman papillomavirus types in the lower genital tract correlateswith cervical dysplasia[].JMed Virol.2001

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部